SEC EDGARAUG 251 min read$AMPX

Sun Kang sold $642K of AMPX

Sun Kang sold 62,101 shares of Amprius Technologies, Inc. (AMPX) at $10.34 ($0.64M total) on 2026-08-21.

Original reporting

SEC EDGAR · Sun Kang

Published Aug 25, 2026, 9:22 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 25, 2026, 9:24 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$AMPX

Neutral

high confidence

Mentioned

$AMPX

Relevance

5/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$AMPXNeutralLow

Why it matters

The disclosed sale is modest and unlikely to affect market perception of AMPX.

Market read

Routine insider sale with limited trading relevance.

What to watch

Potential upcoming financing needs or personal liquidity needs for the director.

Relevance 5/10Novelty 4/10Timing: post-market filing

Background

SEC Form 4 filing discloses insider transactions; used by traders to gauge insider sentiment.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$AMPXNeutralHigh confidence

Context

Director Sun Kang sold 62,101 shares for $642,186, reducing his stake to 1,218,397 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale size is small relative to float and market cap; typical for insiders.

Market effects

Sector

None significant; insider sale does not affect sector trends.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

If insider selling signals concerns, a short position could be considered, but evidence is weak.

Key entities

Company
Amprius Technologies, Inc.
US-listed battery technology company (ticker AMPX).
Insider
Sun Kang
Director of Amprius Technologies.

Read at source ← All news

OCT 21

$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.

stockstotrade.com2 min

OCT 14

$AMPXMed

Canaccord initiates Amprius Technologies stock with buy rating

Canaccord initiated coverage on Amprius Technologies (AMPX) with a Buy rating and $14 target, citing 144% revenue growth and market dominance. The company reported Q2 revenue of $34.02M, beating estimates, and raised full-year guidance. AMPX has a Strong Buy consensus with targets ranging from $18 to $30.

investing.com2 min

SEP 28

$AMPXHighAI 8/10

Amprius Secures $75 Million Grant for American High-Energy Density Battery Production

Amprius (NYSE: AMPX) received a $75M grant from the U.S. Department of War to convert an EV battery line for high-energy density cells for drones. The $100M project, with a South Korean partner, aims to produce 12M cells annually by early 2028, meeting NDAA sourcing requirements.

suasnews.com2 min

SEP 28

$AMPXHighAI 9/10

Amprius Technologies stock jumps on $75M defense grant

Amprius Technologies (AMPX) shares rose 11% after receiving a $75M grant from the U.S. Department of War to convert a battery production line for unmanned aerial systems. The project, costing $100M, aims to produce 12M cells annually by early 2028, supporting NDAA-compliant domestic sourcing. The grant will expand Amprius' manufacturing capabilities in the U.S.

investing.com1 min

AUG 26

$AMPXMed

Amprius technologies director Kang Sun sells $642,186 in stock

Amprius Technologies director Kang Sun sold 62,101 shares for $642,186 to cover tax obligations. The stock is down 4.2% this week. Amprius reported Q2 revenue of $34.02M, beating estimates, and raised its full-year revenue guidance to at least $140M. The company has $74.5M in cash and no debt.